Skip to content

Analysis of acute metabolic impacts of the RUTF "Plumpy'Nut" regarding ketogenesis in healthy adults by measurement of beta-hydroxybutyrate serum levels

Analysis of acute metabolic impacts of the RUTF "Plumpy'Nut" regarding ketogenesis in healthy adults by measurement of beta-hydroxybutyrate serum levels

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00039133
Enrollment
11
Registered
2026-02-26
Start date
2019-05-25
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immediate effect of Plumpy'Nut intake on anabolic metabolism (measured by ketogenesis) with regard to the risk of refeeding syndrome

Interventions

Group 1: The study aims to demonstrate the effects of the ready-to-use supplementary food 'Plumpy'Nut' on ketogenesis in healthy adults based on changes in beta-hydroxybutyrate concentration in the bl

Sponsors

Universitätsklinikum Münster, Klinik für Kinder- und Jugendmedizin, Allgemeine Pädiatrie, Bereich Angeborene Stoffwechselerkrankungen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Ketogenic metabolic state after 3 days of food deprivation (verified by own beta-hydroxybutyrate measurements) - No metabolic diseases (diabetes mellitus, hyperinsulinemia) - No endocrine diseases (Cushing's syndrome, hyper-/hypothyroidism) - Non-smoker - No regular intake of medication - No intake of nutritional supplements at least 7 days before and during the intervention period - Pregnancy/breastfeeding - BMI < 30 - No mental illness, including eating disorders - No blood donation during the fasting period or two weeks before and after

Exclusion criteria

Exclusion criteria: -Pregnancy/breastfeeding -Diabetes mellitus/hyperinsulinemia metabolic disorders -Endocrine disorders (Cushing's syndrome, hyper-/hypothyroidism) -Peanut allergy, lactose intolerance -Drug addiction/alcohol abuse -Smokers -Mental illness, including eating disorders (bulimia, anorexia) -BMI > 30 -Regular intake of medication/nutritional supplements

Design outcomes

Primary

MeasureTime frame
The target criterion (?Diff) is defined as the difference between the maximum change of beta-hydroxybutyrate levels following Plumpy’Nut® intake (?ßOHBPlumpy’Nut®) and the beta-hydroxybutyrate fluctuations on day 3 (?ßOHBDay3). H0 ?Diff = ?ßOHBPlumpy’Nut® - ?ßOHBDay3 = 0 H1 ?Diff ? 0

Secondary

MeasureTime frame
In Addition we monitored the blood glucose levels while fasting and hourly for 5 hours after the intervention. Insulin, vitamin B1, phosphate, potassium, sodium, calcium, chloride, cholesterol, HDL, LDL and triglycerides were measured in the blood before and hourly for 5 hours after the intervention

Countries

Germany

Contacts

Public ContactThorsten Marquardt

Universitätsklinikum Münster, Klinik für Kinder- und Jugendmedizin, Allgemeine Pädiatrie, Bereich Angeborene Stoffwechselerkrankungen

thorsten.marquardt@ukmuenster.de+49 2518356494

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026